Navigation Links
Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership

NORTH ATTLEBORO, Mass., July 20 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a full-service regulatory consulting and contract research organization (CRO) serving the medical device and diagnostics industry, today announced a strategic partnership with Clinical Development & Support Services Ltd (CDSS), a clinical services and CRO based in Cheshire, England.  This relationship will allow clients access to the best of both organizations' core strengths and geographical expertise.  The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation activities.

Leslie Rose, Director of Clinical Services at MDCI said, "Our primary aim is to fully support clients as they design and conduct medical device and IVD clinical trials both in the US and Europe. The CDSS network of employee and contract clinical research professionals in the UK and across Europe complements MDCI's full service CRO activities.  This collaboration of two former competitors combines our strengths to provide broader and deeper clinical and regulatory solutions for all of our medical device clients."

John Illingworth, Manager Director at CDSS said, "We recognize that our clients need to ensure their clinical research plans meet International regulatory requirements especially in the US and Europe.  MDCI's extensive regulatory expertise and network of clinical research professionals in the US makes our alliance a perfect match to achieve this.  The blend of both CDSS' and MDCI's skills and infrastructure will allow us to provide all the benefits of working with a large, multinational CRO, whilst retaining the personal, tailored service that both companies pride themselves on."

About MDCI

MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  By leveraging MDCI's comprehensive knowledge of FDA and international regulations, clients capture and grow market share, increase productivity, and stay competitive in an increasingly complex global marketplace.  MDCI has offices in Massachusetts and California.  Additional information is available at

About CDSS

CDSS has over 30 years experience in providing a wide range of clinical development services to medical device, pharmaceutical and biotechnology companies within the healthcare industry, specialising in Phase I to Phase IV clinical trials and in the provision of monitoring and contract research nursing services.  CDSS is the UK's leading independent research nurse provider.  Having worked with clients in the UK, Europe and the US, ranging from small start-up companies to large multinational corporations and the National Health Service (NHS), CDSS recognises the individual requirements of clients and provides a service tailored to individual needs.  By working closely with the British Consulate across the US, CDSS can help to provide information on and access to any R&D grants, funding or tax credits, which may be available.  CDSS has offices in the North of England and Massachusetts, USA.   Additional information is available at

SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
(Date:10/13/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a ... serving the pharmaceutical, biotechnology, and medical device industries, ... version of OncoWuXi, the first App in the ... and data on the go.  The OncoWuXi App ... to identify relevant tumor models for use in ...
(Date:10/13/2015)... Oct. 13, 2015  The Wyss Institute ... today announced the launch of its latest ... will introduce imaging reagents providing super-resolution capabilities ... of expensive specialized instruments. The announcement follows ... Office of Technology Development (OTD) and ...
(Date:10/13/2015)... -- --> --> Opportunities ... the Asthma and COPD Therapies market? Which areas are going ... new report shows you potential revenues to 2025, assessing data, ... 260 tables, charts, and graphs. Discover the most lucrative areas ... study lets you assess forecasted sales at overall world market ...
Breaking Medicine Technology:
(Date:10/13/2015)... MA (PRWEB) , ... October 13, 2015 , ... Protein ... of the body, including muscle, bone, and blood. But how much protein does the ... complicated than it might seem, according to the October 2015 issue of Harvard ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System and Centegra ... than 59,000 emergency department visits per year, today announced the successful and rapid ... improve clinical, operational and financial outcomes. , In less than four ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, ... the newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to ... leading professional in Obstetrics and Gynecology and a pioneer in the field of ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... and the Florida Apartment Association (FAA) has partnered with the Florida Department of ... the demand. , The FAA Smoke-Free Multifamily Housing Program launched last week ...
Breaking Medicine News(10 mins):